金域医学（603882）(603882.SH)发布公告，公司预计2025年年度实现归属于上市公司股东的净利润 为-1.3亿元到-1.9亿元，与上年同期相比，将同比减亏19,124.11万元到25,124.11万元。 ...

Core Viewpoint - HCA Healthcare has projected its profit for 2026 to exceed Wall Street estimates, driven by anticipated lower costs and strong demand for its medical care services [1] Summary by Relevant Categories Financial Forecast - The company expects its profit for 2026 to be above Wall Street estimates [1] Cost Management - HCA Healthcare anticipates lower costs contributing to its profit forecast [1] Demand for Services - The company is experiencing robust demand for its medical care services, which supports its positive outlook [1]

冬日的北京，寒意渐浓。近日于北大国际医院内举行的开放日活动，却涌动着关乎生命与希望的暖流。在北京与深圳两地同步举行的这场活动中，两个普通 人惊心动魄却又充满温度的生命故事引人关注。一位企业高管在常规体检中被"截停"了即将爆发的心梗，一位23岁的青年在历经29次手术后重获"新生"。 他们的经历，如同两把钥匙，意外而精准地开启了观察中国平安"综合金融+医疗养老"战略核心业务成员北大医疗的一扇窗。面对医疗服务领域长期存在 的"重医不重防、检出无人问、院后无人管"的痛点，北大医疗集团所构建的"健—医—康"全周期服务闭环，正在尝试给出自己的答案。 生命"哨站"：北大国际医院的"防"与"断" "护士长过来跟他说，你不要紧张，120马上到了。"在开放日活动中，一位年轻的家属站上台，他代替无法到场的舅舅，讲述了一个关于"一次体检截停一场 心梗"的故事。 氧气面罩、急救药物、心电图监护迅速到位，120急救电话同步拨出。从体检中心的超声探头发现端倪，到救护车呼啸着将其送至最近的阜外医院，并在心 脏主要血管堵塞超过90%的危急情况下成功植入支架，全程未超过一小时。"他后来跟我说，特别后怕。如果再拖俩月，可能就见不着了。" 家属的感 ...

（记者 曾健辉） 每经AI快讯，成都先导1月27日晚间发布业绩预告，预计2025年年度实现归属于母公司所有者的净利润 为1.04亿元~1.27亿元，与上年同期相比，将增加5264.29万元~7564.29万元，同比增加 102.5%~147.29%。业绩变动主要原因是，主营业务影响。2025年公司通过与全球合作伙伴建立长期稳 定的深度协作，商业项目按计划推进。DEL作为公司的基石业务报告期内保持了稳步增长，且该业务保 持了较高的毛利率，带来了利润的整体提升；与此同时，英国子公司进一步巩固了FBDD/SBDD平台的 稳步发展，主要业务板块收入实现稳步增长的同时，DEL和FBDD/SBDD客户项目取得阶段性进展，均 实现对应项目里程碑收入。新技术业务板块方面的商业转化逐步显现：OBT板块在持续拓展传统核苷单 体合成业务的同时，报告期内借助递送分子相关服务，实现了小核酸一站式项目的商业转化，报告期内 收入同比增长显著；报告期内公司自主设计并搭建的自动化高通量化学合成平台高效运转，带动了 ChemSer收入的同比增长。公司主营业务收入稳健增长及毛利率同步提升带来了本期利润增加。 每经头条（nbdtoutiao）——国 ...

证券之星消息，1月27日医疗服务板块较上一交易日下跌1.13%，昭衍新药领跌。当日上证指数报收于 4139.9，上涨0.18%。深证成指报收于14329.91，上涨0.09%。医疗服务板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 002524 | 光正眼科 | 5.56 | 10.10% | 117.70万 | | 6.09亿 | | 600568 | ST中珠 | 2.79 | 3.72% | 43.82万 | | 1.22亿 | | 688796 | 百奧賽图 | 70.86 | 3.14% | 2.81万 | | 1.96 (Z | | 920670 | 数字人 | 19.44 | 3.02% | 5.51万 | | 1.06亿 | | 002173 | 创新医疗 | 28.82 | 2.27% | 56.09万 | | 15.69 Z | | 301201 | 诚达药业 | 41.58 | 2.16% | 5.43万 | | 2.26亿 | | 6 ...

Core Viewpoint - The establishment of national regional medical centers aims to bring top-tier medical resources closer to the public, enhancing convenience and peace of mind for patients [1]. Group 1: Medical Center Development - The Zhejiang Provincial People's Hospital's Bijie Hospital has been officially approved as a national regional medical center project, allowing more local residents to access high-quality medical services nearby [1]. - The construction of the medical center is part of a broader initiative to leverage regional and sectoral support for healthcare improvements in Bijie City [1]. Group 2: Technological Advancements - The hospital has introduced 258 new technologies and projects over three years, including the establishment of the first 5G remote robotic surgery center in Guizhou Province, successfully performing the first 5G ultra-remote robotic surgery in Southwest China [3]. - The ability to treat previously untreatable conditions and perform minimally invasive surgeries has significantly improved the hospital's technical capabilities [3]. Group 3: Talent Development - The hospital has focused on both attracting external experts and cultivating local talent, creating a robust medical team that is capable of independent operations [3]. - A "blood-making" training approach has been implemented, allowing young professionals to grow into competent medical staff [3]. Group 4: Service Improvement - Management and service at the hospital have become more patient-centered, optimizing processes to enhance the overall patient experience [4]. - Initiatives such as the medical team leader responsibility system and "one bed for the whole hospital" management have been introduced to improve resource allocation and operational efficiency [4]. - The hospital leadership actively seeks feedback from frontline staff to adapt services to patient needs, ensuring a more efficient and satisfying healthcare experience [4].

Group 1: Core Development Goals - The "14th Five-Year" period has seen significant progress in cultural initiatives, enhancing public cultural services for citizens [3] - The "15th Five-Year" plan aims to establish Beijing as a historical and cultural city, focusing on the protection and management of cultural heritage [4][5] - The plan emphasizes the integration of culture, commerce, tourism, and sports to create a comprehensive consumption experience [3] Group 2: Economic and Infrastructure Development - The fixed asset investment target for this year is set to exceed 1 trillion yuan, with a focus on strategic projects and infrastructure improvements [6][7] - Major projects include the implementation of significant industrial and infrastructure initiatives to enhance modern capabilities and public services [7] - The plan includes the establishment of a talent allocation mechanism to support core technology development and innovation [8][9] Group 3: Environmental and Health Initiatives - The "15th Five-Year" period will focus on achieving advanced carbon efficiency levels and improving ecological environments [10][11] - Measures will be taken to enhance the healthcare system, including the establishment of a tiered medical service system and improved access to healthcare resources [13] - The plan aims to promote green and low-carbon transitions in economic and social development [11] Group 4: Housing and Urban Development - The plan includes initiatives for urban renewal, such as the renovation of old elevators and the construction of accessible community spaces [12] - Housing policies will be improved to ensure better living conditions for new citizens and young people, with a focus on rental housing [12] - The goal is to transition from "housing for all" to "housing for livability," enhancing urban living quality [12]

Core Viewpoint - The recent long-term procurement contract worth 600 million yuan between Mingji Hospital and Hefei China reflects both companies' operational anxieties, with Mingji Hospital needing to implement its expansion plans and Hefei China facing significant performance declines due to industry pressures [1][5][8]. Group 1: Company Performance - Hefei China is experiencing a significant downturn, with a projected revenue decline of 26.67% to 689 million yuan for 2025 and a shift from a net profit of 27.57 million yuan to a loss between 25 million and 36 million yuan [5][7]. - The company's losses are attributed to the implementation of centralized procurement policies in the in vitro diagnostics industry, which have drastically reduced procurement prices and squeezed sales revenue and gross margins [7][11]. - Despite cost control measures, Hefei China is unable to reduce fixed expenses proportionally to its declining revenue, leading to continued financial strain [7][11]. Group 2: Strategic Implications - The partnership between Mingji Hospital and Hefei China is driven by Mingji's urgent need for a stable supply chain to support its expansion plans following its recent IPO, where it raised approximately 555 million HKD [8][11]. - Mingji Hospital's operational model is limited by its higher pricing compared to public hospitals and a narrow customer base, which constrains its growth potential [11][15]. - The exclusive supply agreement with Hefei China may limit Mingji Hospital's ability to negotiate prices and manage costs effectively, especially in a context of increasing centralized procurement [11][12]. Group 3: Contractual Risks - The eight-year procurement agreement includes clauses for price adjustments based on market fluctuations, which could significantly impact Hefei China's profit margins and overall financial health [12][15]. - Payment terms require Hefei China to front nearly four months of payment for supplies, increasing its cash flow pressure amid ongoing losses [13][15]. - The lack of clear fallback provisions in the contract raises concerns about potential disputes and the overall stability of the partnership [12][14].

Core Viewpoint - Yonghe Medical (2279.HK) experienced significant trading activity today, with its stock price surging over 20% to reach HKD 2.1, marking a new high since October 2025 [1] Group 1 - The stock price increase indicates strong market interest and potential investor confidence in Yonghe Medical [1] - The rise in stock price reflects a positive trend for the company, achieving a three-month high [1]

甘肃省第十四届人民代表大会第四次会议 政协甘肃省第十三届委员会第四次会议 sterol 解锁2026财局/反时或者就拥有 · 干方百计促进消费 落实城乡居民增收计划,增强居民消费能力 ● · 深入实施提振消费专项行动,扩大优质消费品和 服务供给 挖掘健康、家政、餐饮、物业等服务消费潜力 ● 激发文娱、旅游、体育、教培等改善型消费活力 9 甘肃新媒体集团 甘肃省第十四届人民代表大会第四次会议 政协甘肃省第十三届委员会第四次会议 STETLI 解锁2026防局儿女的民警新期待 · 推进"高等研究院+大学科技园"一体化科技成果 转移模式 · 支持兰州大学建设中国特色世界一流大学 · 深入推进省属高校"双一流"和交叉学科中心建设 。实施人才兴陇计划,完善科技奖励、成果赋权等 激励制度 · 加强知识产权保护应用 甘肃省第十四届人民代表大会第四次会议 政协甘肃省第十三届委员会第四次会议 · 坚持以文塑旅、以旅彰文,推动文旅深度融合发展 · 壮大干亿级文旅融合产业链 · 高水平建设大敦煌文化旅游经济圈 · 发挥红色文化资源优势,推出一批红色旅游研学 线指 · 用好工业遗产,发展工业旅游 日肃新媒体集团 每日目标网 甘肃省第 ...